glp-1 receptor agonists list Injectable Discovery of GLP-1–Based Drugs for

Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial

Discussion This study systematically quantitatively assessed the efficacy and safety characteristics of 12 marketed and experimental GLP-1RA drugs

[DOI] [PubMed] [Google Scholar] 121.Home PD, Shamanna P, Stewart M, Yang F, Miller M, Perry C, Carr MC

Gu G, Roland B, Tomaselli K, Dolman CS, Lowe C, Heilig JS

Success Stories What Our Partners Say Feedback from verified healthcare and research professionals "The compliance-first approach provided clarity from the outset